Heart
Failure Etiology Is Usually Pluricausal Whether or Not There is
Associated Coronary Disease |
to
pdf >>
By
Arthur
L Klatsky, MD;Sharon Gronningen, RN; Natalia Udaltsova, PhD; Douglas
Chartier, MD; Somjot S Brar, MD; James Schipper, MD; Robert J Lundstrom,
MD
Abstract
The
heart failure syndrome (HF) has diverse etiologies. In a 22-year
study of predictors of HF in 126,235 persons, we attempted to
identify etiologic factors independent of associated coronary
heart disease (CAD) in 2594 persons hospitalized for the condition.
For this purpose, subjects were stratified according to whether
CAD was present. Of the subjects, 60% had evidence for CAD (CAD-HF).
Because we also wished to study HF predictors in subjects without
associated CAD according to specific HF etiology, the paper records
of the other 40% of subjects (non-CAD-HF) underwent a detailed
review so that we could determine the apparent primary etiology
and contributory factors. A random sample of all subjects with
CAD-HF underwent a similar paper record review so that we could
ascertain contributory factors. The primary etiology among the
subjects with non-CAD-HF was categorized as systemic hypertension
(HTN) in 354, valve disease in 110, cardiomyopathies (including
alcoholic and idiopathic) in 93, other specific miscellaneous
in 55, and primary etiology not evident (unclear) in 423. The
unclear-group subjects generally had multiple probable contributing
factors. In addition to the preponderant etiology in subjects
with non-CAD-HF, the mean number of contributory factors was 1.5;
among subjects with CAD-HF, the mean number of contributory factors
was 1.9. Frequent additional factors, in both CAD-HF and non-CAD-HF,
were HTN, diabetes mellitus, atrial fibrillation, and heavy alcohol
consumption. These data show that primary HF etiology is often
uncertain and that HF etiology is usually multifactorial, whether
or not CAD is present.
Introduction
The
heart failure (HF) syndrome has diverse etiologies, with comorbid
conditions often contributing to HF development or recurrence.15
Causes of HF have traditionally been classified by singular
disease processes (eg, coronary artery disease [CAD], hypertension
[HTN], valve disease), but clinicians understand the importance
of dealing with all remediable factors.1,4,6 The concept
of multiple risk factors, well established for CAD, is increasingly
being applied to primary and secondary HF prevention.1,4,6
Atherosclerotic
CAD is considered the major cause of HF in developed countries.3,4,6
Thus, established CAD risk factors, such as diabetes mellitus,
HTN, smoking, and lipid abnormalities would be expected to predict
HF associated with CAD.6,7 In a study intended as an
analysis of HF precursors in a large population, we sought to minimize
the confounding problem introduced by the CAD relation, by separating
analyses of predictors of HF associated with CAD (CAD-HF) and of
HF not associated with CAD (non-CAD-HF). We also attempted stratification
of subjects with non-CAD-HF by evident cause. The classification
efforts proved their value by showing apparent disparate roles of
alcohol in CAD-HF and non-CAD-HF.8 Although the classification
process was intended to be part of the infrastructure of the study
and not a data endpoint, we were surprised by some of the results,
especially the difficulty in assigning an evident cause in many
subjects with non-CAD-HF. Because we believe that others might also
benefit from the lessons we learned, we present our observations
here. Our data strongly reinforce the wisdom of the multiple risk
factor approach to HF etiology.
Materials
and Methods
Study
Population and Data
The
study protocols were approved by the Institutional Review Board
of the Kaiser Permanente Medical Care Program. All subjects gave
written informed consent for use of data. Baseline data for 1978
to 1985 were from health examination questionnaires completed by
126,235 members of a comprehensive prepaid health care program in
San Francisco and Oakland, California. The examination9
included self-classified ethnicity, health measurements, and queries
about sociodemographic status, habits, and medical history.
HF
Ascertainment
We screened Health Plan data for persons with 1 primary hospitalization
discharge diagnosis of code 428 ("heart failure") from
the International Classification of Diseases, 9th Revision, Clinical
Modification through December 2000. This yielded a group of
2787 persons. Accepted as having CAD-HF without paper record review
confirmation were 880 subjects with separate discharge diagnoses
of acute myocardial infarction, a coronary intervention, or an angiogram
showing occlusion of 50% diameter of at least one major vessel.
All other records were reviewed for confirmation of HF, using the
Framingham Heart Study HF criteria,10 and for classification
as CAD-HF or non-CAD-HF. We excluded 193 persons, mostly as not
having HF. Of the remaining 2594, 60% (1559) were classified as
having CAD-HF and 40% (1035) were classified as having non-CAD-HF.
We
performed detailed review of all 1035 subjects with non-CAD-HF,
attempting to identify a single probable preponderant HF etiology.
Strict criteria for HF8 were used for classification
of preponderant etiology as HTN, valvular disease, various cardiomyopathies,
etc. Attribution to idiopathic dilated cardiomyopathy required that
there be no apparent preponderant cause or major factors. Alcoholic
cardiomyopathy required evidence of heavy alcohol intake as the
only potential major factor. If there were contributing factors
but none seemed severe enough to be the cause of HF, the etiology
was labeled unclear. Probable contributing factors in addition to
the preponderant etiology were tabulated for the 1035 subjects with
non-CAD-HF. For comparison with respect to contributory factors,
we did a similar detailed review of a randomly selected subset (n
= 263) of all subjects with CAD-HF.
When
data were available (81% of subjects with a paper record review),
we also classified subjects according to left ventricular (LV) systolic
function. If an ejection fraction (EF) estimate was available (n
= 670), it was used to stratify LV function as good (EF 50%), fair
(EF = 35%49%), or poor (EF < 35%). If an imaging study
stated no EF, we used written subjective evaluations (n = 382) or
fractional shortening data (n = 26).
Further
details about methodology have been published.8
Analytic
Methods
Subjects were monitored until one of the following occurred: December
31, 2000, admission for HF at a Health Plan facility, or termination
of Plan membership. The mean duration of follow-up was 14.4 years,
yielding an estimated 1,820,200 person-years. Comparisons of proportions
with individual underlying factors or combinations of factors entailed
the use of c-square tests.
Results
Baseline
Traits of Subjects with CAD-HF and Those with Non-CAD-HF
Persons
with CAD-HF (vs non-CAD-HF) were more likely to be male, white,
obese, and smokers but less likely to be college graduates
or heavy drinkers (Table 1). Mean age at HF diagnosis was similar:
74.0 years for CAD-HF and 73.6 years for non-CAD-HF. Baseline HTN
was present in approximately three quarters of both groups, but
the highest quartile of total cholesterol and glucose levels were
more prevalent in the CAD-HF group.


Baseline
Traits of Etiologic Subgroups of Subjects with Non-CAD-HF
The
preponderant HF etiology among subjects with non-CAD-HF (Table 2)
was judged to be HTN in 354 (34%), valve disease in 110 (11%), cardiomyopathy
in 93 (9%), and unclear in 423 (41%). The remaining
73 had other specific causes (eg, arrhythmia, infection, anemia).
Among the 93 subjects with cardiomyopathy, 31 were judged to have
alcoholic cardiomyopathy, 30 had other specific types, and 32 had
idiopathic cardiomyopathy. Mean age at diagnosis was 72.6 years
for those with HTN, 72.9 years for valve disease, 66.2 years for
those with cardiomyopathy, and 76.3 years for the unclear group.
Disproportionately represented were women in the HTN and valve disease
groups and black persons in the HTN group. Smokers and heavy drinkers
of alcohol were overrepresented in the cardiomyopathy and unclear
groups, and persons with a high body mass index or high blood glucose
level were overrepresented in the HTN group.
Contributing
Factors
The subjects with CAD-HF averaged 1.9 factors in addition to CAD,
making a total of 2.9 factors. Only 7% of those with CAD-HF had
no additional factors, whereas 24% had 3. Subjects with non-CAD-HF
averaged 1.5 factors in addition to the primary etiology, making
a mean total of 2.5 probable factors; 20% of these had 3. Among
unclear-group subjects, almost half (46%) had 3 factors. The small
number of probable factors in the cardiomyopathy group (mean = 0.5)
is a consequence of the exclusionary definitions of idiopathic dilated
cardiomyopathy and alcoholic cardiomyopathy. The remaining subjects
with cardiomyopathy, composed of several small groups (postpartum,
infiltrative, hypertrophic), averaged 1.5 additional factors.
The
frequencies of probable factors (Table 3) indicate important roles
for HTN, diabetes, and atrial fibrillation in both CAD-HF and non-CAD-HF.
The prominent role of HTN in non-CAD-HF is revealed by adding the
354 subjects considered to have HTN as the preponderant etiology
to the 403 others with HTN as a probable factor, making a total
of 757 (73% of those with non-CAD-HF). The role of heavy alcohol
drinking in non-CAD-HF is shown by the 31 subjects with alcoholic
cardiomyopathy and many of the 167 with alcohol as a probable factor,
making a possible total of 198 (19%). By definition, atrial fibrillation
was considered a factor if present at the time of HF diagnosis.
LV
Function Categories
Combining
the subjects with CAD-HF and those with non-CAD-HF with LV function
data, the mean number of factors in addition to the primary etiology
in 430 subjects with good LV function was 1.53; in 268 with fair
LV function, it was 1.62; and in 378 with poor LV function, it was
1.62. These differences are not statistically significant. When
subjects with CAD-HF and those with non-CAD-HF with LV function
data were studied separately, there were also no significant differences
between those in the various LV function categories in the number
of additional factors (data not shown).
Discussion
HF
Etiology Is Often Uncertain
We
anticipated difficulty in ascertaining a preponderant cause in some
subjects with non-CAD-HF but were surprised that the unclear subgroup
was the largest subgroup. Most subjects in the unclear group had
multiple apparent HF factors but no factor appearing strong enough
to be assigned a primary role. Although we cannot rule out some
degree of subjectivity in our judgments, we attempted to assign
primary etiology in subjects with non-CAD-HF to create etiologic
categories. We cannot quantitate the likelihood that the 41% of
those with non-CAD-HF judged unclear is an underestimate or an overestimate.
Whatever the actual proportion of unclear etiologies might be, the
finding clearly indicates a need for caution when determining a
cause of HF.
We
did not attempt to determine whether CAD association with HF meant
CAD etiology. The presence of CAD seemed likely to ensure the predictive
power of CAD risk factors. Causality of CAD for HF involves a more
difficult judgment than presence of CAD. It is not uncommon for
patients with severe CAD but no history or evidence of myocardial
infarction to develop HF. If myocardial infarctions from CAD are
the usual basis of HF, some subjects assigned to the CAD-HF group
by our criteria of CAD association might have HF as a consequence
of other factors.
HF
Usually Has More Than One Probable Causative Factor
Both
the subjects with non-CAD-HF and those with CAD-HF usually had more
than one probable causative factor (Table 4). The importance of
HTN, atrial fibrillation, and diabetes mellitus for both non-CAD-HF
and CAD-HF and of heavy alcohol consumption in non-CAD-HF comes
as no surprise (Table 3). The substantial prevalence of valvular
disease in subjects with CAD-HF is noteworthy and may reflect the
presence of similar risk factors for both.11
Diabetes
May Be an HF Factor Independent of CAD
In
view of the association of diabetes mellitus with vascular pathology
and endothelial dysfunction,12,13 undiagnosed atherosclerotic
or microvascular CAD might explain the substantial apparent role
of diabetes in non-CAD-HF. Additionally there may be an independent
diabetes-specific cardiomyopathy. Reports suggest a disproportionate
association of HF or LV dysfunction in persons with diabetes12,13
or poor glycemic control.14 The diabetic cardiomyopathy
concept is further supported by evidence in patients with diabetes
of myocyte glucolipotoxicity and various metabolic perturbations.15
Strict
Definitions Probably Reduce the Numbers in Some Categories
Exclusionary
definitions resulted in small numbers of subjects with HF attributable
to alcoholic or idiopathic dilated cardiomyopathy. Problems in defining
these entities are well known.1618 Alcoholic cardiomyopathy
is often subclinical,18,19 and alcohol intake is often
underestimated; some unclear-group subjects probably had alcoholic
cardiomyopathy. The true prevalence of alcoholic cardiomyopathy
is higher than the 3% of non-CAD-HF so labeled. Traits influencing
development of alcoholic cardiomyopathy may include genetic factors,
autoimmune phenomena, and other cardiotoxins.8

There
Are Unproven and Unknown HF Factors
An
underlying genetic substrate probably underlies many cases of idiopathic
dilated cardiomyopathy,20 is likely in alcoholic cardiomyopathy,21
and indeed may be present in some proportion of HF cases of almost
any etiology.22 Several studies suggest the importance
of psychosocial factors, especially depression, in HF risk.23
Other factors of possible importance in HF include postinfectious
or other autoimmune conditions22 and nutritional factors.
If we had been able to ascertain these traits, their addition would
have increased the number of factors for many subjects with HF.
This
study is limited by the descriptive nature of the data. Assignment
of HF factors was based on judgments from chart review only of subjects
with HF, precluding case-control comparisons. Use of HF hospitalization
as an endpoint leaves unexplored factors in patients with milder
HF who are not hospitalized. Incomplete follow-up due to Health
Plan termination could affect the data if termination were systematically
related to the traits studied. Incomplete chart review of subjects
with CAD-HF, due to limited resources, resulted in a small proportion
of cases of misdiagnosed HF and of CAD association. We consider
it unlikely that any of these limitations affected our main results.
Conclusion
Ready
attribution of HF to a single underlying cause often does not fit
the facts. In a majority of cases, multiple contributory factors,
rather than a specific medical diagnosis, are involved. It is time
to retire the traditional disease-specific HF classification.
Acknowledgments
This
work was supported by a grant from the Kaiser Foundation Research
Institute; data collection in 19781985 was supported by a
grant from the Alcoholic Beverage Medical Research Foundation of
Baltimore, Maryland.
Katharine
O'Moore-Klopf of KOK Edit provided editorial assistance.
References
-
Kannel WB. Current status of the epidemiology of heart failure.
Curr Cardiol Rep 1999 May;1(1):11-9.
-
Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart
failure: the Framingham Study. J Am Coll Cardiol 1993 Oct;22(4
Suppl A):6A-13A.
-
Bonow RO, Bennett S, Casey DE Jr, et al; American College of
Cardiology; American Heart Association Task Force on Performance
Measures (Writing Committee to Develop Heart Failure Clinical
Performance Measures); Heart Failure Society of America. ACC/AHA
clinical performance measures for adults with chronic heart
failure: a report of the American College of Cardiology/American
Heart Association Task Force on Performance Measures (Writing
Committee to Develop Heart Failure Clinical Performance Measures)
endorsed by the Heart Failure Society of America. J Am Coll
Cardiol 2005 Sep 20;46(6):1144-78.
-
Kenchaiah S, Narula J, Vasan RS. Risk factors for heart failure.
Med Clin North Am 2004 Sep;88(5):1145-72.
-
Tresch DD. Clinical manifestations, diagnostic assessment, and
etiology of heart failure in elderly patients. Clin Geriatr
Med 2000 Aug;16(3):445-56.
-
Campbell DJ. Heart failure: how can we prevent the epidemic?
Med J Aust 2003 Oct 20;179(8):422-5.
-
Klein L, Gheorghiade M. Coronary artery disease and prevention
of heart failure. Med Clin North Am 2004 Sep;88(5):1209-35.
-
Klatsky AL, Chartier D, Udaltsova N, et al. Alcohol drinking
and risk of hospitalization for heart failure with and without
associated coronary artery disease. Am J Cardiol 2005 Aug 1;96:346-51.
-
Collen MF, Davis LF. The multitest laboratory in health care.
J Occup Med 1969 Jul;11(7):355-60.
-
McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history
of congestive heart failure: the Framingham Heart Study. N Engl
J Med 1971 Dec 23;285(26):1441-6.
-
Hughes BR, Chahoud G, Mehta JL. Aortic stenosis: is it simply
a degenerative process or an active atherosclerotic process?
Clin Cardiol 2005 Mar;28(3):111-4.
-
Tenenbaum A, Motro M, Fisman EZ, et al. Status of glucose metabolism
in patients with heart failure secondary to coronary artery
disease. Am J Cardiol 2002 Sep 1;90(5):529-32.
-
Scognamiglio R, Avogaro A, Negut C, et al. Early myocardial
dysfunction in the diabetic heart: current research and clinical
applications. Am J Cardiol 2004 Apr 22;93(8A):17A-20A.
-
Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart
failure among adult patients with diabetes. Circulation 2001
Jun 5;103(22):2668-73.
-
Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation
of the heart in diabetes: Part II: potential mechanisms. Circulation
2002 Apr 16;105(15):1861-70.
-
Roberts WC. Defining idiopathic dilated cardiomyopathy: a courtroom
discussion. Am J Cardiol 1989;63:893-6.
-
Kasper EK, Agema WR, Hutchins GM, et al. The causes of dilated
cardiomyopathy: a clinicopathologic review of 673 consecutive
patients. J Am Coll Cardiol 1994 Mar 1;23(3):586-90.
-
Urbano-Marquez A, Estruch R, Navarro-Lopez F, et al. The effects
of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989
Feb 16;320(7):409-15.
-
Klatsky AL. Drink to your health? Sci Am 2003 Feb;288(2):74-81.
-
Pasotti M, Repetto A, Tavazzi L, Arbustini E. Genetic predisposition
to heart failure. Med Clin North Am 2004 Sep;88(5):1173-92.
-
Fernandez-Sola J, Nicolas JM, Oriola J, et al. Angiotensin-converting
enzyme gene polymorphism is associated with vulnerability to
alcoholic cardiomyopathy. Ann Intern Med 2002 Sep 3;137(5 Part
1):321-6.
-
Luppi P, Rudert WA, Zanone MM, et al. Idiopathic dilated cardiomyopathy:
a superantigen-driven autoimmune disease. Circulation 1998 Aug
25;98(8):777-85.
- Rumsfeld
JS, Havranek E, Masoudi FA, et al. Cardiovascular Outcomes Research
Consortium. Depressive symptoms are the strongest predictors
of short-term declines in health status in patients with heart
failure. J Am Coll Cardiol 2003 Nov 19;42(10):1811-7.